Fertility Supplements Capsules: Gender-Specific Formulations Backed by Clinical Evidence

Why Gender-Specific Formulation Is Non-Negotiable

The evidence base for male and female fertility supplements is fundamentally different. Combining them into a single "unisex" pill means neither partner receives adequate support.

Approximately 40–50% of infertility cases involve male factors, yet most commercial fertility supplements target women exclusively or offer a "couple's pack" where the male formula contains token doses of L-carnitine (50 mg vs. 1,000–2,000 mg in clinical trials) and negligible CoQ10.

When we develop fertility capsule programs at Runxin, we create entirely separate formulations for each partner — different active profiles, different dose levels, and different supporting ingredients.

Product Specifications

The Three Transparency Gaps That Destroy Consumer Trust

After reviewing hundreds of fertility supplement labels, we see the same three problems repeated across the industry. Addressing them is the foundation of every formula we build.

Gap 1: Proprietary Blends Hide Sub-Therapeutic Doses

A "Fertility Matrix Blend 800 mg" with no per-ingredient breakdown makes it impossible for consumers — or clinicians — to verify whether any single ingredient reaches its clinical trial dose.

The clinical reality:

• Myo-inositol: Trials use 2,000–4,000 mg/day. Products listing "inositol" in a proprietary blend often contain 200–400 mg — one-tenth of the studied dose.
• CoQ10: Female fertility trials use 100–600 mg/day; male trials use 200–300 mg/day. Token doses of 20–50 mg are common in blended products.
• L-Carnitine: Male fertility trials use 1,000–2,000 mg/day. Products with "carnitine" in a blend typically deliver 50–100 mg.

Our approach: Every ingredient is listed with its exact quantity per serving. No proprietary blends. We help brands match clinical trial doses so the product delivers what the science supports.

Gap 2: Unspecified Nutrient Forms Reduce Bioavailability

"Folate" on a label could mean folic acid (synthetic, requires MTHFR enzyme conversion) or L-methylfolate (biologically active, works regardless of MTHFR genotype). Approximately 50–55% of people of European ancestry carry at least one copy of the MTHFR C677T variant, which reduces enzyme activity by 35–70%.

Similarly, "CoQ10" could be ubiquinone (oxidized form) or ubiquinol (reduced, more bioavailable form). The distinction matters, especially for women over 35 and for male fertility applications.

Our approach: We specify every nutrient form in the formulation brief and help brands justify the cost differential to consumers through transparent labeling.

Gap 3: Mineral Interactions Are Ignored

Fertility formulas often contain iron, zinc, calcium, and selenium — minerals that compete for the same absorption pathways when taken simultaneously. Iron and zinc share intestinal transporters; calcium inhibits iron absorption by up to 50–60%; high-dose zinc depletes copper.

A formula that throws all these minerals into one capsule and claims "complete fertility support" is chemically compromised before it reaches the consumer.

Our approach:

• For minerals that compete: We recommend split-dose protocols (e.g., iron + folate in morning capsule; zinc + selenium in evening capsule) or time-release capsule systems.
• For minerals that synergize: We pair them strategically (vitamin C + iron enhances absorption; vitamin D3 + calcium optimizes uptake).
• For female formulas: Iron is often excluded or kept minimal so the fertility capsule can be safely stacked with a separate prenatal vitamin without risking iron overload.

Market Context: A USD 2.88 Billion Category Growing at 6.49% CAGR

The global fertility supplements market was valued at USD 2.70 billion in 2025 and is projected to reach USD 3.94 billion by 2031 (Mordor Intelligence, 2026). Key dynamics shaping this market:

The market is bifurcating into two tiers: a high-volume foundational tier (basic folic acid + prenatal vitamins) competing on price with private-label pressure of 25–30%, and a premium science-backed tier (CoQ10, methylfolate, myo-inositol at clinical doses) competing on clinical evidence and ingredient transparency. The premium tier is where manufacturing quality and formulation integrity create defensible brand positions.

Customization Options

Capsule Specifications:

• Size: 0, 00, 000 available
• Shell: HPMC vegetarian, pullulan, or bovine gelatin
• Color: Clear, opaque, bi-tone, or custom

Formulation Paths:

Packaging:

• Bottles (HDPE, PET, glass)
• Blister packs (Alu-Alu, PVC-Alu)
• Sachets or stick packs (for travel-friendly formats)
• Custom labeling, shrink wrapping, and secondary packaging

Certifications Available:

• GMP, ISO9001, ISO22000, FSSC22000, FDA registered, HALAL, HACCP, ECOCERT, REACH

Quality Assurance: From Raw Material to Finished Capsule

Fertility supplements carry heightened responsibility. The end consumer is often planning one of the most important decisions of their life. Quality failures — heavy metal contamination, ingredient substitution, dose variability — don't just damage brands; they affect people trying to build families.

Our quality protocol for fertility capsules:

For fertility-specific quality concerns:

• Methylfolate potency retention: L-methylfolate is sensitive to heat and moisture. We use moisture-barrier capsule shells and controlled-temperature blending to maintain ≥95% potency through shelf life.
• CoQ10 oxidation protection: Ubiquinol is oxidation-sensitive. We offer nitrogen-flushed encapsulation and opaque capsule shells to protect reduced CoQ10 integrity.
• Inositol ratio verification: We verify myo-inositol:D-chiro-inositol ratio by HPLC to confirm the 40:1 physiological ratio is maintained.

Frequently Asked Questions

Q: Can male and female fertility formulas share the same capsule?

A: Technically yes, but clinically no. The evidence base for male fertility (L-carnitine at 1–2 g, CoQ10 at 200–300 mg, zinc at 15–30 mg) and female fertility (myo-inositol at 2–4 g, methylfolate at 400–800 µg, CoQ10 at 100–200 mg) requires fundamentally different dose levels and active profiles. A unisex formula either under-doses the male actives or over-delivers on female-specific compounds. We strongly recommend separate formulations for each partner.

Q: How long before consumers should expect results?

A: Both egg maturation (~85–90 days) and spermatogenesis (~74 days) follow biological cycles of approximately 3 months. Most clinical studies on fertility supplements run for 3–6 months. We recommend brands communicate this timeline clearly on packaging — consumers who stop after 4 weeks haven't given the product time to work.

Q: Can you formulate with patented ingredients like Shimano's MenaQ7® or Kaneka's Ubiquinol?

A: Yes. We work with branded ingredient suppliers including Kaneka (ubiquinol), Gnosis (Quatrefolic methylfolate), and Pantthenol (D-panthenol). Branded ingredients provide clinical citation support and consumer trust, though they increase raw material costs. We can formulate with branded or generic-grade ingredients based on your positioning.

Q: What regulatory claims are permitted for fertility supplements?

A: In the US (DSHEA) and EU (Food Supplements Directive), fertility supplements are classified as dietary supplements — not medicines. Permitted structure/function claims include "supports reproductive health," "supports healthy ovulation," and "supports normal sperm production." Claims like "treats infertility," "cures PCOS," or "guarantees conception" are prohibited. We help brands navigate compliant labeling for US, EU, UK, and Asia-Pacific markets.

Q: Is myo-inositol safe for long-term use?

A: Myo-inositol has an excellent safety profile. Clinical studies in PCOS populations have used 4,000 mg/day for 6–12 months with no significant adverse effects. It is a naturally occurring sugar alcohol found in foods. The most commonly reported side effect is mild GI discomfort at doses above 4 g, which is dose-dependent and resolves with food intake.

Q: What is the difference between a fertility supplement and a prenatal vitamin?

A: A prenatal vitamin is designed for the nutritional demands of established pregnancy — folate, iron, iodine, vitamin D at levels supporting fetal development. A fertility supplement is designed for the pre-conception window — it includes compounds that support gamete quality (CoQ10, myo-inositol, L-carnitine, higher antioxidant doses) that a prenatal typically does not contain. Many consumers use both: a fertility supplement during the 3+ months of trying to conceive, then switch to a prenatal upon confirmed pregnancy.

Q: What is the minimum order quantity?

A: The minimum order quantity is 2,000 bottles. Small batch trial production is supported, which is suitable for new brands to test market response with their first order.

Q: How long is the delivery time?

A: The sample takes 5-7 working days. Batch production takes 3-4 weeks (including the entire process of raw material procurement, production, quality inspection, and packaging). Customized formula development for the first order takes approximately 4-6 weeks.

Ready to Build a Fertility Capsule Line?

Contact us to discuss your fertility supplement capsule project. Whether you need a gender-specific pair, a single-formula preconception complex, or a clinic-grade product line, our formulation team will build a product that matches clinical evidence — not marketing trends.

Our team responds within 24 hours with formulation recommendations and a preliminary cost structure.

Related articles:

• Custom Capsule Supplements Manufacturer
• Custom Herbal & Botanical Capsule Supplement Manufacturing
• Mushroom Supplement Capsules Contract Manufacturing
• Vitamin & Mineral Capsule Manufacturing
• Sports & Performance Capsule Manufacturing
• Metabolic, Detox & Weight Management Capsules
• skin care capsule

Related Products：

• NMNH Capsules
• NMN Hard Capsule
• Collagen Capsules